Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning
NCT05519774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2025-03-07
Summary
The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done twice to see if changes are detected similarly on both types of measures.
Conditions
- Brain Fog
Sponsors & Collaborators
-
The University of Texas at Dallas
collaborator OTHER -
Inova Health Care Services
lead OTHER
Principal Investigators
-
Adam Cohen, MD · Inova Health Care Services
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2024-06-18
- Completion
- 2024-10-18
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer
NCT00713141 ·Status: COMPLETED
-
Biomarkers for Chemotherapy Associated Neurotoxicity
NCT05280262 ·Status: UNKNOWN ·Phase: NA
-
Morbidity After Diagnosis and Treatment of Breast Cancer Patients
NCT00027118 ·Status: COMPLETED
-
Breast Cancer Survivorship & Work-Related Cognitive Limitation
NCT02303145 ·Status: COMPLETED
-
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NCT01286233 ·Status: UNKNOWN
-
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
NCT00496613 ·Status: COMPLETED
-
Intelligent Remote Intervention for High-risk Breast Cancer Populations
NCT06193707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT06212440 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Detection of Residual Cancer in Breast Cancer
NCT03321929 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions
NCT05510037 ·Status: COMPLETED
-
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients
NCT01473680 ·Status: TERMINATED
-
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092 ·Status: RECRUITING
-
Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer
NCT04364672 ·Status: WITHDRAWN ·Phase: PHASE1
-
Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer
NCT04862078 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT02688257 ·Status: COMPLETED
-
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
NCT05507879 ·Status: RECRUITING
-
A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer
NCT02613923 ·Status: COMPLETED ·Phase: NA
-
Mild Cognitive Impairment in Breast Cancer Patients
NCT01949376 ·Status: COMPLETED
-
Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy
NCT01257152 ·Status: COMPLETED
-
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
NCT01468649 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms
NCT01110174 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
NCT04145947 ·Status: UNKNOWN
-
The Memorial Sloan-Kettering Cancer Center (MSKCC
NCT01509963 ·Status: COMPLETED
-
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
NCT05906407 ·Status: RECRUITING